{ "run": { "id": "cmnr14mle057ep658z64y6t71", "region": "US", "assetId": "cmnr14mkx057ap658vder30xg", "ticker": "MRSH", "snapshotId": "cmnr14ml7057cp6583mnllb9h", "promptTemplateId": "cmnqt07si0005lm3jzpxuu1ux", "createdAt": "2026-04-09T05:21:26.112Z", "promptTemplate": { "id": "cmnqt07si0005lm3jzpxuu1ux", "name": "Oficial 08.apr.2026", "version": 1 }, "snapshot": { "id": "cmnr14ml7057cp6583mnllb9h", "assetId": "cmnr14mkx057ap658vder30xg", "asOf": "2026-04-08T20:00:02.000Z", "snapshot": { "asOf": "2026-04-08T20:00:02.000Z", "quote": { "asOf": "2026-04-08T20:00:02.000Z", "open": null, "price": 175.81, "dayLow": 171.86, "volume": 1354165, "dayHigh": 175.96, "currency": "USD", "prevClose": 172.66, "week52Low": 164.89, "week52High": 239.34 }, "fundamentals": { "pe": 21.877358490566, "beta": 0.63006968438692, "epsTTM": 8.48, "fcfTTM": 4961000000, "growth": { "epsYoy": null, "revenueYoy": null }, "sector": "Insurance Agents, Brokers & Service", "margins": { "net": 0.1541825729216856, "gross": null, "operating": 0.230643786368185 }, "website": "https://marsh.com", "industry": "Insurance brokers", "pegRatio": 8.2139536878216, "ebitdaTTM": 6773000000, "forwardPe": null, "marketCap": 107422546097, "totalCash": 2687000000, "totalDebt": 20854000000, "debtEquity": 1.36167156382631, "quickRatio": 0.4917853751187085, "revenueTTM": 26981000000, "companyName": "MARSH & MCLENNAN COMPANIES, INC.", "priceToBook": 2.41939760956175, "currentRatio": 1.101614434947768, "dividendYield": 0.0184981236205999, "returnOnAssets": 0.07085675353432123, "returnOnEquity": 0.271629121776037, "analystOpinions": null, "businessSummary": "Marsh & McLennan Companies, Inc., doing business as Marsh McLennan and Marsh, is a global professional services firm, headquartered in New York City with businesses in insurance brokerage, risk management, reinsurance services, talent management, investment advisory, and management consulting. Its four main operating companies are Marsh (53% of 2024 revenues), which offers risk management, insurance broking, insurance program management, risk consulting, analytical modeling and alternative risk financing services; Marsh Re (formerly Guy Carpenter; 10% of 2024 revenues), a reinsurance intermediary and advisor; Mercer (23% of 2024 revenues), which provides consulting to employers for health insurance, retirement plans, and pension plans; and Oliver Wyman (14% of 2024 revenues), including Lippincott and NERA Economic Consulting, which provides consulting services. In 2024, risk and insuranc…", "enterpriseValue": 109257320000, "analystTargetLow": null, "analystTargetHigh": null, "analystTargetMean": null, "fullTimeEmployees": 90000, "sharesOutstanding": 484124253, "enterpriseToEbitda": 16.13130370589104, "analystTargetMedian": null, "enterpriseToRevenue": 4.04941699714614, "operatingCashflowTTM": 5292000000, "analystRecommendationKey": null } }, "createdAt": "2026-04-09T05:21:26.107Z" }, "results": [ { "id": "cmnr14mlg057gp658kdrdflhm", "runId": "cmnr14mle057ep658z64y6t71", "modelId": "anthropic", "status": "SUCCESS", "rawOutput": "{\"model\":\"AI Equity Research Model v1.0\",\"as_of\":\"2026-04-08T20:00:02.000Z\",\"ticker\":\"MRSH\",\"currency\":\"USD\",\"current_price\":175.81,\"target_price_6m\":190,\"target_price_12m\":202,\"recommendation\":\"BUY\",\"confidence\":0.62,\"thesis_bullets\":[\"Trading ~26% below 52-week high offers compelling entry for quality compounder\",\"Insurance brokerage model generates resilient recurring revenue and strong FCF\",\"FCF yield ~4.6% and ROE ~27% indicate efficient capital deployment\",\"PEG of 8.2x signals modest organic growth; acquisition integration key catalyst\",\"Elevated leverage at 1.36x D/E and macro headwinds temper near-term enthusiasm\"],\"key_drivers\":[{\"driver\":\"Organic revenue growth in Risk & Insurance segment\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"McGriff acquisition integration and synergy realization\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Operating margin expansion toward 24-25% range\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Defensive low-beta profile attracts capital in volatile markets\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Steady dividend yield ~1.85% supports total return\",\"impact\":\"LOW\",\"direction\":\"POS\"},{\"driver\":\"Elevated debt load constrains capital allocation flexibility\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Slowing global economic growth impacts consulting & advisory fees\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Hard insurance market potentially peaking, softening could pressure commissions\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"High PEG ratio suggests limited EPS growth priced in\",\"impact\":\"LOW\",\"direction\":\"NEG\"}],\"risks\":[\"Macroeconomic downturn reduces demand for consulting and advisory services\",\"Insurance market cycle softening compresses brokerage commissions\",\"Acquisition integration risk with McGriff deal execution and leverage\",\"Talent retention challenges across Mercer and Oliver Wyman divisions\",\"Regulatory or antitrust scrutiny of insurance brokerage concentration\"],\"assumptions\":{\"revenue_cagr_3y\":0.065,\"ebit_margin_target\":0.245,\"wacc\":0.085,\"terminal_multiple\":16.5},\"scenarios\":{\"bear\":{\"target_price\":155,\"prob\":0.2,\"notes\":\"Recession-driven revenue decline, multiple compression to ~18x P/E.\"},\"base\":{\"target_price\":202,\"prob\":0.55,\"notes\":\"Mid-single-digit organic growth, margin expansion, ~23x forward P/E on ~$8.80 EPS.\"},\"bull\":{\"target_price\":235,\"prob\":0.25,\"notes\":\"Synergy upside plus re-rating toward historical premium at ~25x forward P/E.\"}},\"method_notes\":\"Blended P/E and EV/EBITDA framework using TTM fundamentals. Base case assumes ~5% EPS growth to ~$8.80-$9.00, 22-23x forward P/E. Stock near 52wk low provides margin of safety for quality compounder. High PEG and elevated debt moderate conviction. Probability-weighted expected value ~$200 supports BUY. Not investment advice.\"}", "parsedJson": { "as_of": "2026-04-08T20:00:02.000Z", "model": "AI Equity Research Model v1.0", "risks": [ "Macroeconomic downturn reduces demand for consulting and advisory services", "Insurance market cycle softening compresses brokerage commissions", "Acquisition integration risk with McGriff deal execution and leverage", "Talent retention challenges across Mercer and Oliver Wyman divisions", "Regulatory or antitrust scrutiny of insurance brokerage concentration" ], "ticker": "MRSH", "currency": "USD", "scenarios": { "base": { "prob": 0.55, "notes": "Mid-single-digit organic growth, margin expansion, ~23x forward P/E on ~$8.80 EPS.", "target_price": 202 }, "bear": { "prob": 0.2, "notes": "Recession-driven revenue decline, multiple compression to ~18x P/E.", "target_price": 155 }, "bull": { "prob": 0.25, "notes": "Synergy upside plus re-rating toward historical premium at ~25x forward P/E.", "target_price": 235 } }, "confidence": 0.62, "assumptions": { "wacc": 0.085, "revenue_cagr_3y": 0.065, "terminal_multiple": 16.5, "ebit_margin_target": 0.245 }, "key_drivers": [ { "driver": "Organic revenue growth in Risk & Insurance segment", "impact": "HIGH", "direction": "POS" }, { "driver": "McGriff acquisition integration and synergy realization", "impact": "HIGH", "direction": "POS" }, { "driver": "Operating margin expansion toward 24-25% range", "impact": "MED", "direction": "POS" }, { "driver": "Defensive low-beta profile attracts capital in volatile markets", "impact": "MED", "direction": "POS" }, { "driver": "Steady dividend yield ~1.85% supports total return", "impact": "LOW", "direction": "POS" }, { "driver": "Elevated debt load constrains capital allocation flexibility", "impact": "MED", "direction": "NEG" }, { "driver": "Slowing global economic growth impacts consulting & advisory fees", "impact": "MED", "direction": "NEG" }, { "driver": "Hard insurance market potentially peaking, softening could pressure commissions", "impact": "MED", "direction": "NEG" }, { "driver": "High PEG ratio suggests limited EPS growth priced in", "impact": "LOW", "direction": "NEG" } ], "method_notes": "Blended P/E and EV/EBITDA framework using TTM fundamentals. Base case assumes ~5% EPS growth to ~$8.80-$9.00, 22-23x forward P/E. Stock near 52wk low provides margin of safety for quality compounder. High PEG and elevated debt moderate conviction. Probability-weighted expected value ~$200 supports BUY. Not investment advice.", "current_price": 175.81, "recommendation": "BUY", "thesis_bullets": [ "Trading ~26% below 52-week high offers compelling entry for quality compounder", "Insurance brokerage model generates resilient recurring revenue and strong FCF", "FCF yield ~4.6% and ROE ~27% indicate efficient capital deployment", "PEG of 8.2x signals modest organic growth; acquisition integration key catalyst", "Elevated leverage at 1.36x D/E and macro headwinds temper near-term enthusiasm" ], "target_price_6m": 190, "target_price_12m": 202 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "anthropic", "webSearch": { "enabled": false, "maxToolCalls": 2, "disabledReason": null }, "pauseTurns": 0, "stopReason": "end_turn" }, "sanityIssues": [] }, "latencyMs": 40730, "createdAt": "2026-04-09T05:21:26.112Z", "usage": { "inputTokens": 3702, "outputTokens": 1611, "costUsd": 0.058785 } }, { "id": "cmnr14mlg057jp6583ngz3e6j", "runId": "cmnr14mle057ep658z64y6t71", "modelId": "deepseek.reasoner", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"AI Equity Research Model\",\n \"as_of\": \"2026-04-08T20:00:02.000Z\",\n \"ticker\": \"MRSH\",\n \"currency\": \"USD\",\n \"current_price\": 175.81,\n \"target_price_6m\": 173.0,\n \"target_price_12m\": 176.4,\n \"recommendation\": \"HOLD\",\n \"confidence\": 0.6,\n \"thesis_bullets\": [\n \"Mature insurance brokerage with stable cash flows and global presence.\",\n \"Revenue growth estimated at 4% annually, driven by market expansion.\",\n \"High operating margins around 23% support consistent earnings generation.\",\n \"Current P/E of 22x suggests valuation is near fair value.\",\n \"Low beta of 0.63 indicates defensive stock characteristics.\"\n ],\n \"key_drivers\": [\n { \"driver\": \"Economic growth\", \"impact\": \"MED\", \"direction\": \"POS\" },\n { \"driver\": \"Interest rates\", \"impact\": \"MED\", \"direction\": \"NEG\" },\n { \"driver\": \"Regulatory environment\", \"impact\": \"HIGH\", \"direction\": \"NEG\" },\n { \"driver\": \"Technology integration\", \"impact\": \"MED\", \"direction\": \"POS\" },\n { \"driver\": \"M&A opportunities\", \"impact\": \"LOW\", \"direction\": \"POS\" },\n { \"driver\": \"Competitive pressure\", \"impact\": \"MED\", \"direction\": \"NEG\" },\n { \"driver\": \"Dividend policy\", \"impact\": \"LOW\", \"direction\": \"POS\" }\n ],\n \"risks\": [\n \"Economic recession reducing demand for insurance services.\",\n \"Increased competition from digital brokers affecting margins.\",\n \"Adverse regulatory changes in key markets like US or EU.\",\n \"Currency volatility impacting international earnings.\"\n ],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.04,\n \"ebit_margin_target\": 0.23,\n \"wacc\": 0.07,\n \"terminal_multiple\": 20\n },\n \"scenarios\": {\n \"bear\": { \"target_price\": 152.64, \"prob\": 0.3, \"notes\": \"Lower growth and multiple compression due to economic slowdown.\" },\n \"base\": { \"target_price\": 176.4, \"prob\": 0.5, \"notes\": \"Modest growth and stable valuation multiples.\" },\n \"bull\": { \"target_price\": 197.78, \"prob\": 0.2, \"notes\": \"Stronger growth and multiple expansion from operational efficiency.\" }\n },\n \"method_notes\": \"Valuation based on EPS growth and P/E multiples. Recommendation HOLD due to limited upside vs current price. Not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T20:00:02.000Z", "model": "AI Equity Research Model", "risks": [ "Economic recession reducing demand for insurance services.", "Increased competition from digital brokers affecting margins.", "Adverse regulatory changes in key markets like US or EU.", "Currency volatility impacting international earnings." ], "ticker": "MRSH", "currency": "USD", "scenarios": { "base": { "prob": 0.5, "notes": "Modest growth and stable valuation multiples.", "target_price": 176.4 }, "bear": { "prob": 0.3, "notes": "Lower growth and multiple compression due to economic slowdown.", "target_price": 152.64 }, "bull": { "prob": 0.2, "notes": "Stronger growth and multiple expansion from operational efficiency.", "target_price": 197.78 } }, "confidence": 0.6, "assumptions": { "wacc": 0.07, "revenue_cagr_3y": 0.04, "terminal_multiple": 20, "ebit_margin_target": 0.23 }, "key_drivers": [ { "driver": "Economic growth", "impact": "MED", "direction": "POS" }, { "driver": "Interest rates", "impact": "MED", "direction": "NEG" }, { "driver": "Regulatory environment", "impact": "HIGH", "direction": "NEG" }, { "driver": "Technology integration", "impact": "MED", "direction": "POS" }, { "driver": "M&A opportunities", "impact": "LOW", "direction": "POS" }, { "driver": "Competitive pressure", "impact": "MED", "direction": "NEG" }, { "driver": "Dividend policy", "impact": "LOW", "direction": "POS" } ], "method_notes": "Valuation based on EPS growth and P/E multiples. Recommendation HOLD due to limited upside vs current price. Not investment advice.", "current_price": 175.81, "recommendation": "HOLD", "thesis_bullets": [ "Mature insurance brokerage with stable cash flows and global presence.", "Revenue growth estimated at 4% annually, driven by market expansion.", "High operating margins around 23% support consistent earnings generation.", "Current P/E of 22x suggests valuation is near fair value.", "Low beta of 0.63 indicates defensive stock characteristics." ], "target_price_6m": 173, "target_price_12m": 176.4 }, "errorsJson": { "attempts": [], "providerMeta": { "endpoint": "https://api.deepseek.com/v1/chat/completions", "provider": "deepseek", "webSearch": { "enabled": false, "supported": false }, "responseFormat": "json_object" }, "sanityIssues": [] }, "latencyMs": 461, "createdAt": "2026-04-09T05:21:26.112Z", "usage": { "inputTokens": 2200, "outputTokens": 3946, "costUsd": 0.002273 } }, { "id": "cmnr14mlg057hp6589o18ueqe", "runId": "cmnr14mle057ep658z64y6t71", "modelId": "gemini.3-pro", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"Equity Research Analyst AI\",\n \"as_of\": \"2026-04-08T20:00:02.000Z\",\n \"ticker\": \"MRSH\",\n \"currency\": \"USD\",\n \"current_price\": 175.81,\n \"target_price_6m\": 187.50,\n \"target_price_12m\": 199.50,\n \"recommendation\": \"BUY\",\n \"confidence\": 0.72,\n \"thesis_bullets\": [\n \"Dominant market position in global insurance brokerage provides a significant competitive moat.\",\n \"Hard insurance market conditions drive higher commission revenue across core risk segments.\",\n \"Mercer and Oliver Wyman segments benefit from complex global regulatory and economic shifts.\",\n \"Strong free cash flow supports consistent dividend growth and opportunistic share repurchases.\",\n \"Proven track record of accretive M&A enhances geographic reach and product capabilities.\"\n ],\n \"key_drivers\": [\n {\n \"driver\": \"Commercial insurance premium rates\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Fiduciary interest income\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Organic revenue growth\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Operating margin expansion\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"M&A execution and integration\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Global GDP growth\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n }\n ],\n \"risks\": [\n \"Cyclical downturn in consulting project demand.\",\n \"Transition to a soft insurance market reducing commissions.\",\n \"Increased competition from digital-native brokerage platforms.\",\n \"Regulatory changes impacting commission transparency and structures.\"\n ],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.075,\n \"ebit_margin_target\": 0.245,\n \"wacc\": 0.078,\n \"terminal_multiple\": 18.5\n },\n \"scenarios\": {\n \"bear\": {\n \"target_price\": 158.00,\n \"prob\": 0.2,\n \"notes\": \"Soft market pricing and significant consulting revenue contraction.\"\n },\n \"base\": {\n \"target_price\": 199.50,\n \"prob\": 0.6,\n \"notes\": \"Sustained mid-single digit organic growth and steady margin stability.\"\n },\n \"bull\": {\n \"target_price\": 230.00,\n \"prob\": 0.2,\n \"notes\": \"Accelerated M&A activity and prolonged hard insurance market cycle.\"\n }\n },\n \"method_notes\": \"Valuation utilizes a 21.5x forward P/E multiple and a 5-year DCF model. Recommendation reflects ~13.5% expected 12-month return based on defensive compounding. Not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T20:00:02.000Z", "model": "Equity Research Analyst AI", "risks": [ "Cyclical downturn in consulting project demand.", "Transition to a soft insurance market reducing commissions.", "Increased competition from digital-native brokerage platforms.", "Regulatory changes impacting commission transparency and structures." ], "ticker": "MRSH", "currency": "USD", "scenarios": { "base": { "prob": 0.6, "notes": "Sustained mid-single digit organic growth and steady margin stability.", "target_price": 199.5 }, "bear": { "prob": 0.2, "notes": "Soft market pricing and significant consulting revenue contraction.", "target_price": 158 }, "bull": { "prob": 0.2, "notes": "Accelerated M&A activity and prolonged hard insurance market cycle.", "target_price": 230 } }, "confidence": 0.72, "assumptions": { "wacc": 0.078, "revenue_cagr_3y": 0.075, "terminal_multiple": 18.5, "ebit_margin_target": 0.245 }, "key_drivers": [ { "driver": "Commercial insurance premium rates", "impact": "HIGH", "direction": "POS" }, { "driver": "Fiduciary interest income", "impact": "MED", "direction": "POS" }, { "driver": "Organic revenue growth", "impact": "HIGH", "direction": "POS" }, { "driver": "Operating margin expansion", "impact": "MED", "direction": "POS" }, { "driver": "M&A execution and integration", "impact": "MED", "direction": "POS" }, { "driver": "Global GDP growth", "impact": "MED", "direction": "POS" } ], "method_notes": "Valuation utilizes a 21.5x forward P/E multiple and a 5-year DCF model. Recommendation reflects ~13.5% expected 12-month return based on defensive compounding. Not investment advice.", "current_price": 175.81, "recommendation": "BUY", "thesis_bullets": [ "Dominant market position in global insurance brokerage provides a significant competitive moat.", "Hard insurance market conditions drive higher commission revenue across core risk segments.", "Mercer and Oliver Wyman segments benefit from complex global regulatory and economic shifts.", "Strong free cash flow supports consistent dividend growth and opportunistic share repurchases.", "Proven track record of accretive M&A enhances geographic reach and product capabilities." ], "target_price_6m": 187.5, "target_price_12m": 199.5 }, "errorsJson": { "attempts": [], "providerMeta": { "model": "gemini-3-flash-preview", "provider": "gemini", "webSearch": { "used": false, "allowed": false, "enabled": false, "requested": false, "disabledReason": null } }, "sanityIssues": [] }, "latencyMs": 16123, "createdAt": "2026-04-09T05:21:26.112Z", "usage": { "inputTokens": 2520, "outputTokens": 792, "costUsd": 0.014544 } }, { "id": "cmnr14mlg057fp658cqr2j5r2", "runId": "cmnr14mle057ep658z64y6t71", "modelId": "openai.gpt-5.4", "status": "SUCCESS", "rawOutput": "{\"model\":\"OpenAI o3\",\"as_of\":\"2026-04-08T20:00:02.000Z\",\"ticker\":\"MRSH\",\"currency\":\"USD\",\"current_price\":175.81,\"target_price_6m\":181.5,\"target_price_12m\":185,\"recommendation\":\"HOLD\",\"confidence\":0.62,\"thesis_bullets\":[\"High-retention brokerage franchise supports resilient recurring fee growth.\",\"Strong cash generation funds dividends, buybacks, and tuck-in acquisitions.\",\"Margins are already strong, limiting additional operating leverage.\",\"Consulting businesses add some economic sensitivity versus pure brokerage peers.\",\"Current valuation looks fair for mid-single-digit earnings growth.\"],\"key_drivers\":[{\"driver\":\"Client retention and renewals\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Commercial P&C rate environment\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Reinsurance cycle strength\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Mercer consulting demand\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Tuck-in acquisition execution\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Wage inflation\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Leverage and interest burden\",\"impact\":\"LOW\",\"direction\":\"NEG\"},{\"driver\":\"Valuation multiple compression\",\"impact\":\"HIGH\",\"direction\":\"NEG\"}],\"risks\":[\"Insurance pricing softens faster than expected.\",\"Consulting demand weakens in a slower macro environment.\",\"Acquisition integration or execution missteps.\",\"Regulatory, litigation, or compliance costs rise.\",\"Higher rates pressure refinancing and valuation multiples.\"],\"assumptions\":{\"revenue_cagr_3y\":7,\"ebit_margin_target\":24.5,\"wacc\":8,\"terminal_multiple\":21},\"scenarios\":{\"bear\":{\"target_price\":158,\"prob\":0.25,\"notes\":\"Pricing softens and consulting demand weakens, driving modest de-rating.\"},\"base\":{\"target_price\":185,\"prob\":0.5,\"notes\":\"Mid-single-digit growth and stable margins support roughly fair-value returns.\"},\"bull\":{\"target_price\":208,\"prob\":0.25,\"notes\":\"Sustained insurance pricing and solid consulting demand allow premium valuation.\"}},\"method_notes\":\"Blended earnings-power and EV/EBIT assessment using snapshot margins, cash flow, leverage, and assumed mid-single-digit growth. Snapshot quote fields kept authoritative; requested ticker MRSH appears to map to Marsh & McLennan. No sell-side targets used. HOLD matches ~5% 12M upside near fair value; not investment advice.\"}", "parsedJson": { "as_of": "2026-04-08T20:00:02.000Z", "model": "OpenAI o3", "risks": [ "Insurance pricing softens faster than expected.", "Consulting demand weakens in a slower macro environment.", "Acquisition integration or execution missteps.", "Regulatory, litigation, or compliance costs rise.", "Higher rates pressure refinancing and valuation multiples." ], "ticker": "MRSH", "currency": "USD", "scenarios": { "base": { "prob": 0.5, "notes": "Mid-single-digit growth and stable margins support roughly fair-value returns.", "target_price": 185 }, "bear": { "prob": 0.25, "notes": "Pricing softens and consulting demand weakens, driving modest de-rating.", "target_price": 158 }, "bull": { "prob": 0.25, "notes": "Sustained insurance pricing and solid consulting demand allow premium valuation.", "target_price": 208 } }, "confidence": 0.62, "assumptions": { "wacc": 8, "revenue_cagr_3y": 7, "terminal_multiple": 21, "ebit_margin_target": 24.5 }, "key_drivers": [ { "driver": "Client retention and renewals", "impact": "HIGH", "direction": "POS" }, { "driver": "Commercial P&C rate environment", "impact": "HIGH", "direction": "POS" }, { "driver": "Reinsurance cycle strength", "impact": "MED", "direction": "POS" }, { "driver": "Mercer consulting demand", "impact": "MED", "direction": "POS" }, { "driver": "Tuck-in acquisition execution", "impact": "MED", "direction": "POS" }, { "driver": "Wage inflation", "impact": "MED", "direction": "NEG" }, { "driver": "Leverage and interest burden", "impact": "LOW", "direction": "NEG" }, { "driver": "Valuation multiple compression", "impact": "HIGH", "direction": "NEG" } ], "method_notes": "Blended earnings-power and EV/EBIT assessment using snapshot margins, cash flow, leverage, and assumed mid-single-digit growth. Snapshot quote fields kept authoritative; requested ticker MRSH appears to map to Marsh & McLennan. No sell-side targets used. HOLD matches ~5% 12M upside near fair value; not investment advice.", "current_price": 175.81, "recommendation": "HOLD", "thesis_bullets": [ "High-retention brokerage franchise supports resilient recurring fee growth.", "Strong cash generation funds dividends, buybacks, and tuck-in acquisitions.", "Margins are already strong, limiting additional operating leverage.", "Consulting businesses add some economic sensitivity versus pure brokerage peers.", "Current valuation looks fair for mid-single-digit earnings growth." ], "target_price_6m": 181.5, "target_price_12m": 185 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "openai", "webSearch": { "used": false, "enabled": false, "sources": [], "maxToolCalls": 2 }, "responseId": "resp_01eb8f29ad5f4b010069d75b7b864081968aa9c49796b38068", "reasoningEffort": "medium", "structuredOutputs": { "used": true, "requested": true, "disabledReason": null } }, "sanityIssues": [] }, "latencyMs": 32265, "createdAt": "2026-04-09T05:21:26.112Z", "usage": { "inputTokens": 2470, "outputTokens": 1873, "costUsd": 0.030544 } }, { "id": "cmnr14mlg057ip658ccg6a2zl", "runId": "cmnr14mle057ep658z64y6t71", "modelId": "xai.grok-4.20-reasoning", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"AI Equity Analyst Model\",\n \"as_of\": \"2026-04-08T20:00:02.000Z\",\n \"ticker\": \"MRSH\",\n \"currency\": \"USD\",\n \"current_price\": 175.81,\n \"target_price_6m\": 185,\n \"target_price_12m\": 198,\n \"recommendation\": \"BUY\",\n \"confidence\": 0.62,\n \"thesis_bullets\": [\n \"Leading global insurance broker with high client retention\",\n \"Diversified operations across risk, consulting and reinsurance\",\n \"Consistent organic growth and margin improvement track record\",\n \"Strong free cash flow funding dividends and strategic M&A\",\n \"Current valuation reflects fair balance of growth and risks\"\n ],\n \"key_drivers\": [\n {\n \"driver\": \"Organic growth in insurance brokerage\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Expansion in Mercer and Oliver Wyman\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Insurance pricing and demand cycles\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Exposure to global economic conditions\",\n \"impact\": \"HIGH\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Debt levels and interest rate sensitivity\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Regulatory and compliance risks\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Talent and compensation cost inflation\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Successful execution of digital initiatives\",\n \"impact\": \"LOW\",\n \"direction\": \"POS\"\n }\n ],\n \"risks\": [\n \"Economic downturn impacting client spending\",\n \"Intense competition eroding market share\",\n \"Failure to integrate acquisitions effectively\",\n \"Changes in insurance market dynamics\"\n ],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.075,\n \"ebit_margin_target\": 0.24,\n \"wacc\": 0.085,\n \"terminal_multiple\": 18\n },\n \"scenarios\": {\n \"bear\": {\n \"target_price\": 145,\n \"prob\": 0.25,\n \"notes\": \"Recession hampers growth across all segments.\"\n },\n \"base\": {\n \"target_price\": 198,\n \"prob\": 0.5,\n \"notes\": \"Steady execution on organic growth and efficiency.\"\n },\n \"bull\": {\n \"target_price\": 235,\n \"prob\": 0.25,\n \"notes\": \"Accelerated M&A and robust pricing power.\"\n }\n },\n \"method_notes\": \"DCF valuation anchored on 7.5% revenue CAGR, 24% EBIT margin, 8.5% WACC and 18x terminal EV/EBIT. Base case implies 13% upside; not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T20:00:02.000Z", "model": "AI Equity Analyst Model", "risks": [ "Economic downturn impacting client spending", "Intense competition eroding market share", "Failure to integrate acquisitions effectively", "Changes in insurance market dynamics" ], "ticker": "MRSH", "currency": "USD", "scenarios": { "base": { "prob": 0.5, "notes": "Steady execution on organic growth and efficiency.", "target_price": 198 }, "bear": { "prob": 0.25, "notes": "Recession hampers growth across all segments.", "target_price": 145 }, "bull": { "prob": 0.25, "notes": "Accelerated M&A and robust pricing power.", "target_price": 235 } }, "confidence": 0.62, "assumptions": { "wacc": 0.085, "revenue_cagr_3y": 0.075, "terminal_multiple": 18, "ebit_margin_target": 0.24 }, "key_drivers": [ { "driver": "Organic growth in insurance brokerage", "impact": "HIGH", "direction": "POS" }, { "driver": "Expansion in Mercer and Oliver Wyman", "impact": "MED", "direction": "POS" }, { "driver": "Insurance pricing and demand cycles", "impact": "HIGH", "direction": "POS" }, { "driver": "Exposure to global economic conditions", "impact": "HIGH", "direction": "NEG" }, { "driver": "Debt levels and interest rate sensitivity", "impact": "MED", "direction": "NEG" }, { "driver": "Regulatory and compliance risks", "impact": "MED", "direction": "NEG" }, { "driver": "Talent and compensation cost inflation", "impact": "MED", "direction": "NEG" }, { "driver": "Successful execution of digital initiatives", "impact": "LOW", "direction": "POS" } ], "method_notes": "DCF valuation anchored on 7.5% revenue CAGR, 24% EBIT margin, 8.5% WACC and 18x terminal EV/EBIT. Base case implies 13% upside; not investment advice.", "current_price": 175.81, "recommendation": "BUY", "thesis_bullets": [ "Leading global insurance broker with high client retention", "Diversified operations across risk, consulting and reinsurance", "Consistent organic growth and margin improvement track record", "Strong free cash flow funding dividends and strategic M&A", "Current valuation reflects fair balance of growth and risks" ], "target_price_6m": 185, "target_price_12m": 198 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "xai", "webSearch": { "used": false, "enabled": false, "sources": [], "maxToolCalls": 2 }, "responseId": "bb5eec63-eb7a-9b95-9907-2276e323dedc", "usedFallbackChatCompletions": false }, "sanityIssues": [] }, "latencyMs": 14070, "createdAt": "2026-04-09T05:21:26.112Z", "usage": { "inputTokens": 2802, "outputTokens": 3335, "costUsd": 0.058431 } } ] } }